Phenol esters
Medchemexpress LLC Splitomicin | 5690-03-9 | MFCD08705254 | 98.4% | 198.22 g/mol | C13H10O2 | 10 MG
Splitomicin is a small-molecule selective inhibitor of Sir2p (an NAD+-dependent deacetylase) used in research to modulate sirtuin activity and study chromatin regulation, cell cycle, and DNA damage pathways. Supplied as a powder, it is appropriate for analytical and laboratory applications.
Medchemexpress LLC Splitomicin | 5690-03-9 | MFCD08705254 | 98.2% | 198.22 g/mol | C13H10O2 | 100 MG
Splitomicin is a selective Sir2p (sirtuin) inhibitor used as a research reagent to study NAD+-dependent histone deacetylase activity and related epigenetic pathways. Supplied as a purified small-molecule, it is intended for in vitro biochemical assays and pathway investigations.
- Selective Sir2p inhibitor to probe NAD+-dependent HDAC activity.
- High reported purity (≈98%) suitable for biochemical assays.
- Molecular weight 198.22 g/mol with formula C13H10O2.
- Available in small pack sizes appropriate for research use, including 100 mg.
- Commonly used in sirtuin pathway and epigenetics studies.
Medchemexpress LLC Splitomicin (splitomycin) | 5690-03-9 | MFCD08705254 | 98.4% | 198.22 g/mol | C13H10O2 | 25 MG
Splitomicin is a small-molecule inhibitor of NAD+-dependent histone deacetylase Sir2 (sirtuin) used in biochemical and cellular research to probe sirtuin-mediated deacetylation and related pathways. It is supplied as a solid research reagent with reported high purity and accompanying safety and technical documentation.
- Selective Sir2/sirtuin inhibition for biochemical assays.
- Suitable for enzymatic and cellular studies investigating deacetylation pathways.
- High purity appropriate for research applications.
- Available in small-scale quantities for experimental use, including 25 mg packs.
- Accompanied by a safety data sheet and product data sheet for handling and characterization.